|
 The order by Superior Court Judge Ioana Petrou in Oakland,
California, comes on the heels of a $289 million verdict in the
first glyphosate trial in San Francisco, in which a jury found
Monsanto liable for causing a school groundskeeper's cancer.
Damages were later reduced to $78 million, and Bayer, which denies
the allegations, said it would appeal the decision.
Its share price, however, has dropped nearly 30 percent since the
Aug. 10 jury verdict and the company faces some 9,300 U.S.
glyphosate lawsuits.
Petrou's ruling clears the way for the second California jury trial
over glyphosate, the world's most widely used weed killer. The trial
of California residents Alva and Alberta Pilliod is scheduled to
begin on March 18, 2019, according to a court filing.
"While we have great sympathy for the plaintiffs, we are confident
that our glyphosate-based herbicides were not the cause of their
injuries and we will vigorously defend them at trial," the company
said in a statement.
Glyphosate jury trials will ramp up next year. The company is
scheduled to face jurors in a Missouri state court in St. Louis,
where the first trial was set to begin in early February. That date,
however, was vacated by a judge, Bayer said, and the trial is likely
to be postponed to later in 2019.
A trial in San Francisco federal court, where federal Roundup
lawsuits are consolidated, is scheduled to begin at the end of
February.
[to top of second column] |
Bayer, which acquired Monsanto earlier this year for $63 billion,
says its glyphosate-based products do not cause cancer, pointing to
decades of scientific studies and regulatory approvals that have
shown the chemical to be safe for human use.
The U.S. Environmental Protection Agency in September 2017 concluded
a decades-long assessment of glyphosate risks and found the chemical
not likely carcinogenic to humans. But the World Health
Organization's cancer arm in 2015 classified glyphosate as "probably
carcinogenic to humans."
The Pilliods, who are in their 70s, allege their regular use of
Roundup between 1975 and 2011 caused them to develop non-Hodgkin
lymphoma, a cancer of the lymph system.
The couple filed their lawsuit in June 2017, after being diagnosed
with the cancer in 2011 and 2015 respectively. Their lawyers earlier
this year asked for an expedited trial, citing the couple's risk of
a relapse and their short life expectancy.
(Reporting by Tina Bellon in New York; Editing by Peter Cooney and
Dan Grebler)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
 |
